StockNews.com Begins Coverage on Enzo Biochem (NYSE:ENZ)

Research analysts at StockNews.com initiated coverage on shares of Enzo Biochem (NYSE:ENZ) in a note issued to investors on Wednesday. The brokerage set a “hold” rating on the medical research company’s stock.

Enzo Biochem Price Performance

Enzo Biochem stock opened at $0.32 on Wednesday. Enzo Biochem has a 52 week low of $0.25 and a 52 week high of $1.28. The stock has a fifty day moving average of $0.44 and a 200-day moving average of $0.75.

Enzo Biochem (NYSE:ENZ) last issued its earnings results on Monday, March 17th. The medical research company reported ($0.02) EPS for the quarter. Enzo Biochem had a negative return on equity of 7.96% and a negative net margin of 75.34%. The business had revenue of $7.33 million for the quarter.

Institutional Trading of Enzo Biochem

Hedge funds and other institutional investors have recently modified their holdings of the stock. Mink Brook Asset Management LLC acquired a new stake in shares of Enzo Biochem during the 4th quarter valued at $577,000. Geode Capital Management LLC boosted its stake in shares of Enzo Biochem by 3.3% during the third quarter. Geode Capital Management LLC now owns 368,646 shares of the medical research company’s stock valued at $413,000 after purchasing an additional 11,742 shares in the last quarter. Wittenberg Investment Management Inc. grew its holdings in shares of Enzo Biochem by 60.1% during the fourth quarter. Wittenberg Investment Management Inc. now owns 187,537 shares of the medical research company’s stock worth $134,000 after purchasing an additional 70,400 shares during the last quarter. Lepercq Multi Asset Fund acquired a new position in shares of Enzo Biochem in the fourth quarter valued at approximately $88,000. Finally, Virtu Financial LLC bought a new position in Enzo Biochem in the 4th quarter valued at approximately $35,000. Institutional investors own 36.90% of the company’s stock.

Enzo Biochem Company Profile

Enzo Biochem, Inc develops, manufactures, and markets products and tools for clinical research, translational research, drug development, and bioscience research customers worldwide. The company offers proteins, antibodies, peptides, small molecules, labeling probes, dyes, and kits, which provide life science researchers tools for target identification/validation, content analysis, gene expression analysis, nucleic acid detection, protein biochemistry and detection, and cellular analysis.